10.7.2014   

EN

Official Journal of the European Union

C 217/35

1.

On 27 June 2014, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Bridgepoint Advisers Group Limited (‘Bridgepoint’, United Kingdom) acquires within the meaning of Article 3(1)(b) of the Merger Regulation, control of the whole of Edmond de Rothschild Capital Partners (‘EdRCP’, France), by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

—   for Bridgepoint: private equity fund controlling a number of entities active in a wide range of industry sectors across the EEA, among others financial services, media and healthcare (including the provision of ophthalmic and dental surgical services in hospitals),

—   for EdRCP: private equity fund holding interests in a number of portfolio companies, active in a wide range of sectors across the EEA and in particular packaging and healthcare products (including the supply of ophthalmic surgical products, dental equipment, dental consumables, dental imaging products and medical devices).

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by email to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number M.7309 — Bridgepoint/EdRCP, to the following address: